Search Results - "Patel, Jeegar"
-
1
Radiological evaluation of OrthAlign-A novel handheld navigation system used in total knee replacement
Published in Journal of pharmacy & bioallied science (01-07-2023)“…Background: The goal of this research is to determine how well OrthAlign, a novel portable navigation system for total knee replacement, helps surgeons make…”
Get full text
Journal Article -
2
Inhibition of glucose transport synergizes with chemical or genetic disruption of mitochondrial metabolism and suppresses TCA cycle-deficient tumors
Published in Cell chemical biology (17-03-2022)“…Efforts to target glucose metabolism in cancer have been limited by the poor potency and specificity of existing anti-glycolytic agents and a poor…”
Get more information
Journal Article -
3
Functional antibody characterization via direct structural analysis and information‐driven protein–protein docking
Published in Proteins, structure, function, and bioinformatics (01-04-2022)“…Detailed description of the mechanism of action of the therapeutic antibodies is essential for the functional characterization and future optimization of…”
Get full text
Journal Article -
4
Outcome of single stage anterior and posterior surgery for tuberculous paraplegia
Published in Journal of pharmacy & bioallied science (01-07-2023)“…Background: Morbidity and mortality from tuberculosis, a significant infectious illness, are expected to rise worldwide. The projected number of new cases rose…”
Get full text
Journal Article -
5
Discovery and Optimization of Glucose Uptake Inhibitors
Published in Journal of medicinal chemistry (28-05-2020)“…Aerobic glycolysis, originally identified by Warburg as a hallmark of cancer, has recently been implicated in immune cell activation and growth. Glucose, the…”
Get full text
Journal Article -
6
A Phase 1 Thorough QT/QTc Study of Therapeutic and Supratherapeutic Doses of Belumosudil in Healthy Subjects
Published in Clinical pharmacology in drug development (01-10-2022)“…Belumosudil is a selective Rho‐associated, coiled‐coil‐containing protein kinase‐2 inhibitor. In this crossover design thorough QT/QTc study, single…”
Get full text
Journal Article -
7
Phase 1 Studies to Evaluate the Food Effect and Relative Bioavailability of Tablet and Capsule Formulations of Belumosudil in Healthy Adult Subjects
Published in Clinical pharmacology in drug development (01-07-2022)“…Belumosudil is a selective Rho‐associated coiled‐coil containing protein kinase 2 inhibitor. A capsule formulation was used during early clinical development…”
Get full text
Journal Article -
8
Absolute Bioavailability, Mass Balance, and Metabolic Profiling Assessment of [14C]‐Belumosudil in Healthy Men: A Phase 1, Open‐Label, 2‐Part Study
Published in Clinical pharmacology in drug development (01-07-2022)“…Belumosudil is a selective Rho‐associated coiled‐coil containing protein kinase 2 (ROCK2) inhibitor. ROCK2 has been shown to drive proinflammatory response and…”
Get full text
Journal Article -
9
652 Anti-PD-L1/IL-15 KD033 activated macrophages and induced anti-tumor immunity in the tumor-microenvironment
Published in Journal for immunotherapy of cancer (01-11-2021)“…BackgroundKD033 is a clinical-stage bispecific fusion molecule consisting of a high-affinity anti-human-PD-L1 antibody and human IL-15. Previous studies with…”
Get full text
Journal Article -
10
573 A novel human anti-PD1/IL15 bi-functional protein with robust anti-tumor activity and low systemic toxicity
Published in Journal for immunotherapy of cancer (01-11-2020)“…BackgroundIL-15 is a key cytokine promoting CD8+ T, NK, and NKT cell proliferation and has demonstrated clinical activity in cancer patients without evidence…”
Get full text
Journal Article -
11
512 Phase I dose escalation of KD033, a PDL1-IL15 bispecific molecule, in metastatic and advanced solid tumors
Published in Journal for immunotherapy of cancer (01-11-2021)“…BackgroundWhile IL-2 and IL-15 signal through the shared IL-2/15 βγ receptor, IL-15 does not directly expand regulatory T cells (Tregs)or mediate…”
Get full text
Journal Article -
12
Modulation of neuronal CXCR4 by the μ-opioid agonist DAMGO
Published in Journal of neurovirology (01-12-2006)“…The chemokine receptor CXCR4 regulates neuronal survival and differentiation and is involved in a number of pathologies, including cancer and human…”
Get full text
Journal Article -
13
Transcriptional profiling of primary human-skin derived mast cell activation by various MRGPRX2 agonists and inhibition with EVO756
Published in The Journal of immunology (1950) (01-05-2024)“…Abstract Mas-related G-protein coupled receptor X2 (MRGPRX2) is a GPCR expressed predominantly by mast cells and has been implicated to play an important role…”
Get full text
Journal Article -
14
Human immunodeficiency virus gp120-induced apoptosis of human neuroblastoma cells in the absence of CXCR4 internalization
Published in Journal of neurovirology (01-06-2006)“…The chemokine receptor CXCR4 functions as human immunodeficiency virus (HIV)-1 coreceptor and is involved in acquired immunodeficiency virus (AIDS)…”
Get full text
Journal Article -
15
Apoptotic and antiapoptotic effects of CXCR4: is it a matter of intrinsic efficacy? Implications for HIV neuropathogenesis
Published in AIDS research and human retroviruses (01-10-2004)“…CXCR4, the specific receptor for the chemokine SDF-1 alpha that also binds CXCR4-using HIV gp120s, affects survival of different cell types, including neurons…”
Get more information
Journal Article -
16
Efficacy of a novel oral, potent, and highly selective PKCt inhibitor in the SCID T-cell transfer colitis model
Published in The Journal of immunology (1950) (01-05-2024)“…Abstract Protein kinase C family theta isoform (PKCt) is a key kinase downstream of T-cell receptor (TCR) and CD28 co-signaling in T-cells, leading to T-cell…”
Get full text
Journal Article -
17
Selective small-molecule PKC-theta inhibitors effectively block TCR-mediated activation of naïve peripheral blood and tissue resident memory T cells
Published in The Journal of immunology (1950) (01-05-2024)“…Abstract Immune mediated inflammatory diseases constitute a diverse set of illnesses in which an aberrant immune response damages self-tissue. While progress…”
Get full text
Journal Article -
18
Evaluation of the clinical molecule anti-human-PD-L1/IL-15 KD033 in the human-PD-1/PD-L1-expressing murine model demonstrates PD-L1 targeting of IL-15 in vivo
Published in Cancer Immunology, Immunotherapy (01-06-2023)“…KD033 is a clinical-stage immunocytokine composed of a high-affinity anti-human-PD-L1 antibody and the human IL-15/ IL-15 receptor sushi-domain complex. We…”
Get full text
Journal Article -
19
ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease
Published in Journal of clinical oncology (10-06-2021)“…The rho-associated coiled-coil-containing protein kinase-2 (ROCK2) signaling pathway regulates the Th17/regulatory T cells balance and controls profibrotic…”
Get full text
Journal Article -
20
Efficacy of KD033, an anti-human-PD-L1-IL-15 bispecific protein, in human-PD-L1 positive and negative murine tumor models
Published in Journal of clinical oncology (20-05-2021)“…Abstract only e14556 Background: KD033 is a clinical-stage bispecific fusion molecule consisting of a high-affinity anti-human-PD-L1 antibody and human IL-15…”
Get full text
Journal Article